SHC · NASDAQ
Sotera Health (SHC) Stock Price & Fundamentals
Sotera Health (SHC) closed at $722.20 on Oct 9, 2026, down 0.55% from the previous close of $726.21.
Share price, past year
1Y +24.19%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $722.20 |
| Sep 30, 2026 | $746.42 |
| Aug 31, 2026 | $697.10 |
| Jul 31, 2026 | $735.89 |
| Jun 30, 2026 | $719.50 |
| May 29, 2026 | $702.48 |
| Apr 30, 2026 | $688.47 |
| Mar 31, 2026 | $665.98 |
| Feb 27, 2026 | $678.84 |
| Jan 30, 2026 | $675.97 |
| Dec 31, 2025 | $653.46 |
| Nov 28, 2025 | $627.78 |
| Oct 31, 2025 | $613.30 |
Key statistics
- Market cap
- $206.10B
- P/E (TTM)
- 1,267.0
- EPS (TTM)
- $0.57
- Revenue (TTM)
- $1.22B
- Net income (TTM)
- $163.48M
- Shares outstanding
- 285.4M
- Dividend yield
- —
- 52-week range
- $576.74 – $752.07
Sotera Health's market cap is $206.10B, based on a share price of $722.20 and 285.4M shares outstanding as of Jul 30, 2026.
Financials
Sotera Health reported revenue of $1.16B for fiscal 2025, up 5.74% from fiscal 2024.
Sotera Health earned net income of $77.95M in fiscal 2025, a net margin of 6.7%.
Fiscal 2025 revenue was the highest in the 7 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $1.16B | +5.7% | $77.95M | 6.7% | $0.27 | $149.18M |
| FY2024ended Dec 31, 2024 | $1.10B | +4.9% | $44.40M | 4.0% | $0.16 | $45.09M |
| FY2023ended Dec 31, 2023 | $1.05B | +4.5% | $51.38M | 4.9% | $0.18 | −$362.71M |
| FY2022ended Dec 31, 2022 | $1.00B | +7.8% | −$233.57M | −23.3% | −$0.83 | $95.58M |
| FY2021ended Dec 31, 2021 | $931.48M | +13.9% | $116.88M | 12.6% | $0.41 | $179.38M |
| FY2020ended Dec 31, 2020 | $818.16M | +5.1% | −$38.62M | −4.7% | −$0.16 | $67.08M |
| FY2019ended Dec 31, 2019 | $778.33M | — | −$20.85M | −2.7% | −$0.09 | $91.78M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $321.38M | $53.64M | $0.19 |
| Q1 FY2026ended Mar 31, 2026 | $280.05M | $26.59M | $0.09 |
| Q4 FY2025ended Dec 31, 2025 | $303.44M | $34.85M | $0.12 |
| Q3 FY2025ended Sep 30, 2025 | $311.31M | $48.40M | $0.17 |
| Q2 FY2025ended Jun 30, 2025 | $294.34M | $7.96M | $0.03 |
| Q1 FY2025ended Mar 31, 2025 | $254.52M | −$13.26M | −$0.05 |
| Q4 FY2024ended Dec 31, 2024 | $290.20M | — | $0.05 |
| Q3 FY2024ended Sep 30, 2024 | $285.47M | $17.00M | $0.06 |
Company profile
- Name
- Sotera Health Co
- Ticker
- SHC
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Services-Misc Health & Allied Services, NEC
- Headquarters
- 9100 South Hills Blvd, Suite 300, Broadview Heights, OH 44147
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001822479
Recent SEC filings
- Aug 14, 2026
- Aug 6, 2026
- Aug 6, 2026
- May 22, 2026
- May 20, 2026
- May 13, 2026
- May 5, 2026
- May 5, 2026
Frequently asked questions
What is Sotera Health's stock price?
Sotera Health (SHC) closed at $722.20 on Oct 9, 2026, down 0.55% from the previous close of $726.21.
What is Sotera Health's market cap?
Sotera Health's market cap is $206.10B, based on a share price of $722.20 and 285.4M shares outstanding as of Jul 30, 2026.
How much revenue does Sotera Health make?
Sotera Health reported revenue of $1.16B for fiscal 2025, up 5.74% from fiscal 2024.
What is SHC's P/E ratio?
Sotera Health's price-to-earnings ratio is 1,267.0, based on trailing twelve-month diluted EPS of $0.57.
Does Sotera Health pay a dividend?
Sotera Health's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Sotera Health Co's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures